The Center for AIDS Research is directed by Douglas D. Richman, MD, who reports directly to the Dean of the School of Medicine. The management of the Center is assisted by its Executive Committee and External Advisory Committee. The Executive Committee consists of Dennis Burton, PhD, of The Scripps Research Institute (TSRI);Nathaniel Landau, PhD, of the Salk Institute;Carl Ware, PhD, of the La Jolla Institute for Allergy and Immunology (LJIAI);and UCSD faculty members, Constance Benson, MD;Igor Grant, MD;J. Allen McCutchan, MD, MSc;and Joshua Fierer, MD. Bruce Torbett, PhD, MSPH, of TSRI has served on the Executive Committee since its creation;however, with the new Protein Expression and Proteomics Core, which he will co-direct, Dr. Burton has agreed to represent TSRI on the Executive Committee in his stead. The External Advisory Board members include Ronald Desrosiers, PhD, New England Regional Primate Research Center, Harvard Medical School;David Ho, MD, Aaron Diamond AIDS Research Center, Rockefeller University;King Holmes, MD, PhD, Harborview Medical Center, University of Washington;Eric Hunter, PhD, Emory University Vaccine Research Center;Gary Nabel, Vaccine Research Center, NIAID/NIH;and Mario Stevenson, PhD, University of Massachusetts Medical School. The Administrative Core organizes and maintains the policies and procedures of the CFAR as a whole, thereby ensuring the efficient operation and management of the Center. To support an effective Center, the Core maintains close ties with University officials, specifically the Office of Contracts and Grants and the Dean's office. Because the CFAR is a multidisciplinary center, the Core collaborates closely with the UCSD Antiviral Research Center, the Owen Clinic, and the HIV Neurobehavioral Research Center, and participates in outreach and educational activities. With the cooperation and support of the Directors, the Administrator, and the support staff, this Core aims to build an efficient infrastructure to streamline policies and procedures for long-term operations. Specifically, the Core will (1) manage the administration of funding to Cores and activities, monitoring any changes in funding levels;(2) organize and sponsor activities such as the monthly CFAR Seminar Series and the CFAR Community Forum;(3) create and maintain the CFAR website;(4) publish the online newsletter;and (5) establish a visible presence in the San Diego community. The Core also generates annual reports to the appropriate officials, facilitates regular meetings of the Executive Committee and the External Advisory Committee, and ensures open lines of communication and collaboration among all CFAR Cores and members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-17
Application #
8080825
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
17
Fiscal Year
2010
Total Cost
$441,975
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications